IP Library Granted Patent US 12,653,782
Granted Patent B2
US 12,653,782 · App. 17/020,692 · Granted Jun 16, 2026

Controlled release concentrate and suspensions including the same

Inventor: Ehsan Moaseri (Austin, TX)
Assignee: Nulixir Inc.
A61K9/10A23L29/10A23L29/30A23L33/155A61K9/0053A61K9/08A61K9/107A61K9/1075A61K9/1652A61K9/1664A61K9/167A61K9/4816A61K9/4833A61K9/4858A61K9/4866A61K9/4875A61K9/4891A61K9/5042A61K9/5089A61K9/513A61K9/5161A61K31/198A61K31/353A61K31/375A61K31/522A61K31/525A61K31/593A61K31/658A61K35/741A61K36/00A61K36/06A61K36/062A61K36/16A61K36/28A61K36/3482A61K36/41A61K36/53A61K36/54A61K36/61A61K36/67A61K36/68A61K47/44A61K45/06B82Y5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,653,782
App. No.
17/020,692
Granted
Jun 16, 2026
Kind
B2
Abstract

Provided is a food and beverage additive having enhanced water solubility, the additive including: an aqueous solution; a first plurality of polymers; a first particle including: a first plurality of lipophilic carriers; a first active ingredient; a first plurality of emulsifying agents; and a second plurality of polymers; wherein the first particle exhibits higher hydrophilicity compared to the first active ingredient; and wherein a plurality of the first particles are uniformly dispersed in the aqueous solution.

Claims (83)

1 . A food or beverage additive having enhanced water solubility, the additive comprising:

an aqueous solution;

a first polymer, wherein the first polymer is selected from the group consisting of gum arabic, alginate, carboxymethyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, starch, xanthan, locust bean gum, pectin, guar gum, and gum acacia;

a first particle comprising:

a first lipophilic carrier;

a first active ingredient;

a first emulsifying agent, wherein the first emulsifying agent is selected from the group consisting of an extract of Quillaja , extract of licorice, polysorbate 20, polysorbate 40, polysorbate 45, polysorbate 60, polysorbate 65, polysorbate 80, polysorbate 81, polysorbate 85, polyglyceryl, gum acacia, polyglycerol polyricinoleate, sorbitan85, sorbitan65, sorbitan83, sorbitan80, sorbitan60, sorbitan40, xanthan gum, sorbitol, mannitol, glycerol, sodium alginate, lecithin, phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, sphingomyelin, cardiolipin, hydrogenated soybean phosphatidylcholine, tocopherol polyethylene glycol succinate, fatty acid mono- and di-glycerides, acetic acid esters of mono- and di-glycerides, lactic acid esters of mono- and di-glycerides, citric acid esters of mono- and di-glycerides, diacetyl tartaric acid ester of mono- and di-glycerides, triglycerol monooleate, hexaglycerol octasterate, polyglycerol esters of oleic acid, decaglycerol mono- and di-oleate, glyceryl caprylate, glyceryl caprate, glyceryl caprate/caprylate, glyceryl monooleate, glyceryl monostearate, poloxamers, milk proteins, casein, pea proteins, whey proteins, and a combination thereof; and

a second polymer, wherein the second polymer is selected from the group consisting of methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, shellac, ethyl methyl cellulose, carboxymethyl cellulose, ethyl cellulose, microcrystalline cellulose, cellulose, 12-hydroxystearic acid, beeswax, candelilla wax, carnauba wax, rice bran wax, and a combination thereof;

wherein;

the first particle exhibits higher hydrophilicity compared to the first active ingredient;

a plurality of the first particles are dispersed in the aqueous solution;

the first particle has a Z-average diameter of smaller than 1 micron, when tested by Dynamic Light Scattering;

the aqueous solution is at least 55% by weight of the additive;

the first active ingredient is at least 5% by weight of the additive;

the first lipophilic carrier is at least 10% by weight of the additive; and

the first active ingredient is less than 50% by weight of the first lipophilic carrier.

2 . The additive of claim 1 , the additive further comprising:

a second emulsifying agents selected from the group consisting of an extract of Quillaja , polysorbate 20, polysorbate 40, polysorbate 45, polysorbate 60, polysorbate 65, polysorbate 80, polysorbate 81 and polysorbate 85, polyglyceryl, gum acacia, xanthan gum, sorbitol, mannitol, glycerol, sodium alginate, and a combination thereof.

3 . The additive of claim 1 , wherein:

the first emulsifying agent has a hydrophilic-lipophilic balance (HLB) of higher than 8; and

the first emulsifying agent is more than 25% by weight of the first lipophilic carrier.

4 . The additive of claim 1 , the additive further comprising:

at least one preservative agent selected from the group consisting of sodium benzoate, sodium metabisulfite, potassium sorbate, sorbic acid, acetic acid, propionic acid, sulfites, nitrites, sodium sorbate, calcium sorbate, benzoic acid, potassium benzonate, and a combination thereof.

5 . The additive of claim 1 , the additive further comprising:

at least one flavoring agent.

6 . The additive of claim 1 , wherein:

the first particle has a Z-average diameter of smaller than 200 nm, when tested by Dynamic Light Scattering.

7 . The additive of claim 1 , wherein:

the first particle has a Z-average diameter of smaller than 500 nm; and

the additive can be stored at room temperature for at least 12 months, with less than 20% change in the Z-average diameter of the first particle.

8 . The additive of claim 1 , wherein:

the second polymer has a first glass transition temperature, wherein the first glass transition temperature is higher than 100° C.;

the first particle has a Z-average diameter of smaller than 500 nm; and

the additive can be stored at temperatures below 85° C. for at least 30 minutes, with less than 20% change in the Z-average diameter of the first particle.

9 . The additive of claim 1 , wherein:

the plurality of the first particles has a polydispersity of less than or equal to 0.25.

10 . The additive of claim 1 , wherein:

the aqueous solution is selected from the group consisting of: water, saline, propylene glycol, or combinations thereof.

11 . The additive of claim 1 , wherein:

the first active ingredient has a concentration of at least 40 milligram per milliliter of the additive.

12 . The additive of claim 1 , wherein:

the first active ingredient comprises a source of cannabinoids, wherein the source of cannabinoids is selected from the group consisting of cannabigerol, cannabigerolic acid, cannabigerolic acid monomethylether, cannabigerol monomethyl ether, cannabichromene, cannabichromanon, cannabichromenic acid, cannabichromevarin, cannabichromevarinic acid, cannabidiol, tetrahydrocannabinol, iso-tetrahydrocannabinol-type, cannabinol, cannabinolic acid, cannabinol methylether, cannabicyclol-type, cannabicyclolic acid, cannabicyclovarin, cannabicitran, cannabitriol, cannabitriolvarin, cannabivarin, cannabifuran, cannabiripsol, and a combination thereof.

13 . The additive of claim 1 , wherein:

at least 30% by weight of the first active ingredient is not released within 60 minutes after consumption.

14 . The additive of claim 1 , the first particle further comprising:

at least one source of bioavailibity enhancer.

15 . The additive of claim 1 , wherein:

the second polymer comprises ethyl cellulose.

16 . The additive of claim 1 , the first particle further comprising:

at least one wax having a melting points exceeding 45° C.

17 . The additive of claim 1 , the first particle further comprising:

a second active ingredient, wherein the second active ingredient is selected from the group consisting of hemp, cannabis, Echinacea purpurea, Echinacea angustifolia, Echinacea pallida, Acmella oleracea, Helichrysum umbraculigerum, Radula marginata , kava, black truffle, Syzygium aromaticum, Rosmarinus officinalis, basil, oregano, lavender, true cinnamon, malabathrum, Cananga odorata , riboflavin, theanine, Ginkgo biloba , bacopa, Rhodiola rosea extract, and a combination thereof.

18 . The additive of claim 1 , wherein:

the first lipophilic carrier is selected from the group consisting of triglycerides, partial glycerides, polyoxyethylated fatty alcohols, polyethylene glycol, vegetable oil, and a combination thereof.

19 . A food or beverage additive having enhanced water solubility, the additive comprising:

an aqueous solution;

a first polymer, wherein the first polymer is selected from the group consisting of gum arabic, alginate, carboxymethyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose, starch, xanthan, locust bean gum, pectin, guar gum, gum acacia, and a combination thereof;

a first particle comprising:

a first lipophilic carrier, wherein the first lipophilic carrier is selected from the group consisting of triglycerides, partial glycerides, polyoxyethylated fatty alcohols, polyethylene glycol, vegetable oil, and a combination thereof;

a first active ingredient, wherein the first active ingredient comprises a source of cannabinoids, wherein the source of cannabinoids is selected from the group consisting of cannabigerol, cannabigerolic acid, cannabigerolic acid monomethylether, cannabigerol monomethyl ether, cannabichromene, cannabichromanon, cannabichromenic acid, cannabichromevarin, cannabichromevarinic acid, cannabidiol, tetrahydrocannabinol, iso-tetrahydrocannabinol-type, cannabinol, cannabinolic acid, cannabinol methylether, cannabicyclol-type, cannabicyclolic acid, cannabicyclovarin, cannabicitran, cannabitriol, cannabitriolvarin, cannabivarin, cannabifuran, cannabiripsol, and a combination thereof;

a first emulsifying agent, wherein the first emulsifying agent is selected from the group consisting of an extract of Quillaja , extract of licorice, polysorbate 20, polysorbate 40, polysorbate 45, polysorbate 60, polysorbate 65, polysorbate 80, polysorbate 81 polysorbate 85, polyglyceryl, gum acacia, Polyglycerol polyricinoleate, sorbitan 85, sorbitan 65, sorbitan 83, sorbitan 80, sorbitan 60, sorbitan 40, xanthan gum, sorbitol, mannitol, glycerol, sodium alginate, lecithin, phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, sphingomyelin, cardiolipin, hydrogenated soybean phosphatidylcholine, hydrogenated soybean phosphatidylcholine, tocopherol polyethylene glycol succinate, fatty acid mono- and di-glycerides, acetic acid esters of mono- and di-glycerides, lactic acid esters of mono- and di-glycerides, citric acid esters of mono- and di-glycerides, diacetyl tartaric acid ester of mono- and di-glycerides, triglycerol monooleate, hexaglycerol octasterate, polyglycerol esters of oleic acid, decaglycerol mono- and di-oleate, glyceryl caprylate, glyceryl caprate, glyceryl caprate/caprylate, glyceryl monooleate, glycerly monostearate, poloxamers, milk proteins, casein, pea proteins, whey proteins, and a combination thereof; and

a second polymer, wherein the second polymer is selected from the group consisting of methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, shellac, ethyl methyl cellulose, carboxymethyl cellulose, ethyl cellulose, microcrystalline cellulose, cellulose, 12-hydroxystearic acid, beeswax, candelilla wax, carnauba wax, rice bran wax, and a combination thereof;

wherein;

the first particle exhibits higher hydrophilicity compared to the first active ingredient;

a plurality of the first particles are uniformly dispersed in the aqueous solution;

the first particle has a Z-average diameter of smaller than 1 micron, when tested by Dynamic Light Scattering;

the aqueous solution is at least 55% by weight of the additive;

the first active ingredient is at least 5% by weight of the additive;

the first lipophilic carrier is at least 10% by weight of the additive; and

the first active ingredient is less than 50% by weight of the first lipophilic carrier.

20 . A food or beverage additive having enhanced water solubility, the additive comprising:

an aqueous solution;

a first polymer, wherein the first polymer comprises xanthan gum

a preservative agent, wherein the first preservative agent is sodium benzoate;

a plurality of particles each comprising:

a first lipophilic carrier, wherein the first lipophilic carrier is a partial glyceride;

a first active ingredient, wherein the first active ingredient comprises a source of cannabinoids, wherein the source of cannabinoids is cannabidiol;

a first emulsifying agent, wherein the first emulsifying agent comprises polysorbate 80; and

a second polymer, wherein the second polymer comprises ethyl methyl cellulose;

wherein the plurality of particles exhibit higher hydrophilicity compared to the first active ingredient;

wherein the plurality of particles are dispersed in the aqueous solution

the plurality of particles have a Z-average diameter of smaller than 200 nm, when tested by Dynamic Light Scattering; and

wherein the plurality particles have a polydispersity of less than or equal to 0.25.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2023
From: MOASERI, EHSAN
To: NULIXIR INC.
Reel/Frame 064523/0798 →
Continuity (5)
Provisional Application 63012058 · Apr 17, 2020
Provisional Application 62968591 · Jan 31, 2020
Provisional Application 62944912 · Dec 6, 2019
Provisional Application 62899595 · Sep 12, 2019
Related Publication 20210169820A1 · Jun 10, 2021
References Cited (127)
US 5827531A · Morrison · 1998 [cited by applicant]
US 6423363B1 · Traska · 2002 [cited by examiner]
US 6720007B2 · Walt et al. · 2004 [cited by applicant]
US 7338924B2 · Varadaraj · 2008 [cited by applicant]
US 9155707B2 · Ying et al. · 2015 [cited by applicant]
US 9427007B2 · Mason et al. · 2016 [cited by applicant]
US 10028919B2 · Kaufman · 2018 [cited by applicant]
US 10738268B2 · Leo · 2020 [cited by applicant]
US 11497809B2 · Wu et al. · 2022 [cited by applicant]
US 20020077372A1 · Gers-Barlag · 2002 [cited by applicant]
US 20030232083A1 · Wynn et al. · 2003 [cited by applicant]
US 20040014821A1 · Varadara · 2004 [cited by applicant]
US 20040192760A1 · Whittle et al. · 2004 [cited by applicant]
US 20050220996A1 · Berger et al. · 2005 [cited by applicant]
US 20080226772A1 · Condeca Brinca et al. · 2008 [cited by applicant]
US 20100055246A1 · Ahn · 2010 [cited by applicant]
US 20100068290A1 · Ziegler et al. · 2010 [cited by applicant]
US 20100226995A1 · DeBrouse · 2010 [cited by applicant]
US 20100273895A1 · Stinchcomb et al. · 2010 [cited by applicant]
US 20100330189A1 · Niichel · 2010 [cited by applicant]
US 20110081451A1 · Siegel et al. · 2011 [cited by applicant]
US 20110111020A1 · Yan et al. · 2011 [cited by applicant]
US 20110182998A1 · Reb et al. · 2011 [cited by applicant]
US 20110189298A1 · Vos et al. · 2011 [cited by applicant]
US 20110195157A1 · Niichel · 2011 [cited by applicant]
US 20120003288A1 · Mori · 2012 [cited by examiner]
US 20120177730A1 · Baron · 2012 [cited by applicant]
US 20130064759A1 · Mason et al. · 2013 [cited by applicant]
US 20140037744A1 · Idcaps · 2014 [cited by applicant]
US 20140242055A1 · Bromley · 2014 [cited by applicant]
US 20150150822A1 · Perumal et al. · 2015 [cited by applicant]
US 20150158004A1 · Meiners et al. · 2015 [cited by applicant]
US 20150209298A1 · Haksar et al. · 2015 [cited by applicant]
US 20160008237A1 · Goldstein et al. · 2016 [cited by applicant]
US 20160128943A1 · Vepuri et al. · 2016 [cited by applicant]
US 20160151328A1 · Doane et al. · 2016 [cited by applicant]
US 20160199378A1 · Niichel · 2016 [cited by applicant]
US 20170105946A1 · Stepovich · 2017 [cited by applicant]
US 20170157049A1 · Dandl et al. · 2017 [cited by applicant]
US 20170172977A1 · Kleidon et al. · 2017 [cited by applicant]
US 20170250063A1 · Chiu et al. · 2017 [cited by applicant]
US 20170281558A1 · Castan et al. · 2017 [cited by applicant]
US 20170367984A1 · Sagalowicz et al. · 2017 [cited by applicant]
US 20180071695A1 · Weitz et al. · 2018 [cited by applicant]
US 20180264059A1 · Speier · 2018 [cited by applicant]
US 20180272308A1 · Sasaki et al. · 2018 [cited by applicant]
US 20180325861A1 · Domb et al. · 2018 [cited by applicant]
US 20180344686A1 · Kleidon et al. · 2018 [cited by applicant]
US 20180360704A1 · Riefler et al. · 2018 [cited by applicant]
US 20180369177A1 · Fayad · 2018 [cited by applicant]
US 20190209633A1 · Speier · 2019 [cited by applicant]
US 20190240148A1 · Rodger et al. · 2019 [cited by applicant]
US 20190254302A1 · Abbaspourrad et al. · 2019 [cited by applicant]
US 20190298683A1 · Friedman · 2019 [cited by examiner]
US 20190321299A1 · Li · 2019 [cited by applicant]
US 20200009067A1 · Hoffman et al. · 2020 [cited by applicant]
US 20200101041A1 · Kleidon · 2020 [cited by applicant]
US 20200138736A1 · Merritt · 2020 [cited by applicant]
US 20210169816A1 · Moaseri · 2021 [cited by applicant]
US 20230157964A1 · Kvitnitsky et al. · 2023 [cited by applicant]
CA 2266518A1 · 1998 [cited by applicant]
CN 1917946A · 2007 [cited by applicant]
CN 101001882A · 2007 [cited by applicant]
CN 101252845A · 2008 [cited by applicant]
CN 103037708A · 2013 [cited by applicant]
CN 104473161A · 2015 [cited by applicant]
CN 104684540A · 2015 [cited by applicant]
CN 104812777A · 2015 [cited by applicant]
CN 105030716A · 2015 [cited by applicant]
CN 105146540A · 2015 [cited by applicant]
CN 105828809A · 2016 [cited by applicant]
CN 107362154A · 2017 [cited by applicant]
EP 2201937A1 · 2010 [cited by applicant]
RU 2634904C1 · 2017 [cited by applicant]
WO 2014151364A1 · 2014 [cited by applicant]
WO 2018183115A1 · 2018 [cited by applicant]
WO 2019071213A1 · 2019 [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/470,994 issued Nov. 22, 2022, pp. 1 to 25. [cited by applicant]
Examination Report for related Chinese Patent Application 202080071670.6 issued on Jan. 28, 2023, 12 pages with English Translation on pp. 1 to 5. [cited by applicant]
International Search Report and Written Opinion in related international application No. PCT/US2020/050772 dated Mar. 17, 2021. [cited by applicant]
Mushiolik, Gerald et al., “Double emulsions relevant to food systems: preparation, stability, and applications”, Comprehensive Reviews in Food Science and Food Safety, 2017, vol. 16, pp. 532-555. [cited by applicant]
Notice of Allowance in related U.S. Appl. No. 17/020,729 dated Mar. 18, 2022, pp. 1-11. [cited by applicant]
International Preliminary Report on Patentability in related international application PCT/US2020/050772 received Mar. 18, 2022, pp. 1-5. [cited by applicant]
Jager-Lezer et al., “A Topical W/O/W Multiple Emulsion Containing Several Active Substances: Formulation, Characterization and Study of Release,” 26 J Control. Rel. 129, 1993, pp. 1-13. [cited by applicant]
Doucet et al., O/W emulsion and W/O/W multiple emulsion: physical characterization and skin pharmacokinetic comparison in the delivery process of caffeine., International Journal of Cosmetic Science, 1998, pp. 283-295. [cited by applicant]
Anton et al., “Aqueous-Core Lipid Nanocapsules for Encapsulating Fragile Hydrophilic and/or Lipophilic Molecules,” Langmuir Article, 25 (19) Jul. 16, 2009, pp. 11413-11419. [cited by applicant]
Raynal et al., “A topical W/O/W multiple emulsion containing several active substances: formulation, characterization and study of release.,” Journal of Controlled Release, 26, 1993 Elsevier Science Publishers B.V., pp.… [cited by applicant]
Moaseri, Ehsan, “Long-Term Colloidal Stability of Polymer-Grafted Silica Nanoparticles in Concentrated Brine at Elevated Temperatures,” Thesis, The University of Texas at Austin, May 2017, pp. 1-65. [cited by applicant]
Nanovex Biotechnologies, “How to Choose the Appropriate Nanovesicle,” https://www.nanovexbiotech.com/choose-appropriate-nanovesicle/, Mar. 15, 2017, pp. 1-6. [cited by applicant]
Guar et al., Nanovesicles of nitrendipine with lipid complex for transdermal delivery: pharmacokinetic and pharmacodynamic studies, Artificial Cells, Nanomedicine, and Biotechnology, https://www.tandfonline.com/doi/full… [cited by applicant]
Non-Final Office Action in related U.S. Appl. No. 17/162,916 dated Jun. 10, 2022, pp. 1-16. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/020,690 issued Apr. 11, 2023, 91 pages. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/854,297 issued Apr. 11, 2023, 32 pages. [cited by applicant]
Notice of Allowance in related U.S. Appl. No. 17/020,697 dated Aug. 17, 2021. [cited by applicant]
Non-Final Office Action in related U.S. Appl. No. 17/020,697 dated Dec. 3, 2020. [cited by applicant]
Notice of Allowance in related U.S. Appl. No. 17/020,693 dated Jan. 26, 2021. [cited by applicant]
Final Office Action in related U.S. Appl. No. 17/020,697 dated Feb. 1, 2021. [cited by applicant]
Choi et al. Characterization of Capsaicin-Loaded Nanoemulsions Stabilized with Alginate and Chitosan by Self-assembly. Food Bioprocess Technol (2011) 4:1119-1126. (Year: 2011). [cited by applicant]
Eister et al. Evaluating the Stability of Double Emulsions—A Review of the Measurement Techniques for the Systematic Investigation of Instability Mechanisms. Colloids Interfaces 2020, 4, 8, 18 pages (review). (Year: 202… [cited by applicant]
Jacobs et al. Phase transitions in biological systems with many components. Biophysical Journal (2017) 112:683-691, (Year: 2017). [cited by applicant]
Madaan et al. Emulsion Technology and Recent Trends in Emulsion Applications. Int. Res. J. Pharm. 2014, 5(7): 533-542 (review). (Year: 2014). [cited by applicant]
Yang et al. Encapsulating plant ingredients for dermocosmetic application: an updated review of delivery systems and characterization techniques. International Journal of Cosmetic Science, 2020, 42, 16-28 (review). (Yea… [cited by applicant]
Corrected Notice of Allowability in related U.S. Appl. No. 17/20,693 dated Feb. 11, 2021. [cited by applicant]
Notice of Allowance in related U.S. Appl. No. 17/162,916 dated Jul. 20, 2022. [cited by applicant]
Final Office Action for related U.S. Appl. No. 17/470,994 issued Aug. 10, 2023, 15 pages. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/020,731 issued May 8, 2023, 109 pages. [cited by applicant]
Extended Search Report for related European Patent Application 20862499.9 received Aug. 4, 2023, 15 pages. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/470,994 issued May 3, 2024, 23 pages. [cited by applicant]
Office Action for related New Zealand Patent Application 809157 issued on May 7, 2024, 4 pages. [cited by applicant]
Office Action for related Canadian Patent Application 3150979 issued on May 17, 2024, 3 pages. [cited by applicant]
Examination Report for related European Patent Application 20862499.9 issued on Aug. 13, 2024, 5 pages. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/020,731 issued Sep. 10, 2024, 54 pages. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/854,297 issued Oct. 30, 2024, 32 pages. [cited by applicant]
Final Office Action for related U.S. Appl. No. 17/470,994 issued Feb. 11, 2025, 19 pages. [cited by applicant]
Notice of Allowance for related U.S. Appl. No. 17/020,731 issued Mar. 4, 2025, 10 pages. [cited by applicant]
Notice of Allowance for related U.S. Appl. No. 17/854,297 issued on Jul. 29, 2025, 15 pages. [cited by applicant]
Non-Final Office Action for related U.S. Appl. No. 17/470,994 issued on Oct. 1, 2025, 17 pages. [cited by applicant]
Office Action for related Canadian Patent Application 3,150,979 issued on Jun. 13, 2025, 3 pages. [cited by applicant]
First Office Action for related Chinese Patent Application 202311227311.7 issued on Jun. 14, 2025, 10 pages with English Translation on pp. 1 to 4. [cited by applicant]
Examination Report for related European Patent Application 20862499.9 issued on Jul. 16, 2025, 5 pages. [cited by applicant]
Preliminary Office Action for related Brazilian Patent Application BR112022004419-4 issued on Jul. 24, 2025, 7 pages with English Translation on p. 1. [cited by applicant]
Office Action for related Canadian Patent Application 3150979 issued on Nov. 10, 2023, 3 pages. [cited by applicant]
Final Office Action for related U.S. Appl. No. 17/854,297 issued on Jan. 11, 2024, 36 pages. [cited by applicant]
Final Office Action for related U.S. Appl. No. 17/020,731 issued on Jan. 30, 2024, 32 pages. [cited by applicant]
Extended European Search Report Issued in European Patent Application No. 22870645.3, dated Oct. 7, 2025, 13 pages. [cited by applicant]
Ezhilarasi, et al. “Nanocapsulation Techniques for Food Bioactive Components: A Review,” Food Bioprocess Technol., vol. 6: pp. 628-647 (2013). [cited by applicant]
Naderinezhad, et al., “Co-Delivery of Hydrophilic and Hydrophobic Anticancer Drugs Using Biocompatible pH-Sensitive Lipid-Based Nano-Carriers for Multidrug-Resistant Cancers,” RSC Adv., vol. 7: 30008 (20174). [cited by applicant]